课题基金 / 基金详情

Hormonal mechanisms of gene regulation

Hormonal mechanisms of gene regulation
基因调控的激素机制
批准号:
RGPIN-2014-04155
负责人:
Zahradka, Peter
金额:
$3.42万
依托单位:
依托单位国家:
加拿大
项目类别:
Discovery Grants Program - Individual
财政年份:
2015
资助国家:
加拿大
项目状态:
已结题
起止时间:
2015-01-01 至 2016-12-31

项目摘要

项目成果

Zahradka, Peter的其他基金

相似基金

相关文献

中文摘要
翻译
背景:胰岛素样生长因子-1(IGF-1)启动的信号转导事件通常被描述为完全依赖于受体酪氨酸激酶的激活。然而,也可能存在一种不同的、依赖于G蛋白的途径。虽然各种数据随后支持了这一初步观察,但解释G蛋白如何介导来自酪氨酸激酶受体的信号的机制尚未确定。 相关发现:在上一期的研究中,我们发现在平滑肌细胞中,IGF-1激活G(I)涉及G(I)与IGF-1受体的直接结合,并表明G-β/γ亚基的激活介导了导致ERK1/2的通路。我们还发现了G(I)-α的几种新的效应因子(ErbB2、EGFR、EIF-4E、组蛋白H_2B)。后者发现的一个独特特征是确定了G(I)通过反式激活机制连接两个受体酪氨酸激酶IGF-1R和ErbB2的作用。 假设:ErbB2的激活需要G(I)与IGF-1受体上的特定位点的结合,ErbB2随后通过调节控制细胞骨架动力学的microRNAs的表达来促进细胞迁移。 目标: 1.确定介导G(I)与IGF-1受体结合的结构因素。 2.探讨ErbB2在IGF-1信号转导、miRNA表达和细胞迁移中的作用。 3.制备免疫印迹法检测单腺苷二磷酸核糖基化的抗体。 实验方法: 1.GST标记的G(I)-α将在下拉实验中作为重组活性IGF-1受体的诱饵。诱饵和受体之间的联系将通过Western blotting进行量化。G(I)-α与IGF-1受体的结合位点将通过重组IGF-1受体的系统突变来定位,首先通过删除10个氨基酸片段,然后在相互作用区域确定后进行单独的点突变。然后,一个不能结合G(I)-α的代表性突变将被克隆到慢病毒载体中,并在用IGF-1攻击的细胞中表达,以验证功能的丧失。 2.分别用ADAM17特异性抑制剂TAPI-2和细胞粘附素抑制剂SecinH3预处理,然后用IGF-1刺激,研究G(I)-α对配体依赖和非配体依赖的ErbB2激活的作用。ERBB2的磷酸化将通过Western blotting进行监测。选择性抑制剂CP-724714将评估ErbB2在细胞迁移和miRNA表达中的作用。MiRNA对ErbB2依赖的迁移的贡献将通过选择性的miRNA敲除来确定。 3.我们设计了一种抗ADP-核糖化精氨酸抗体的抗原。该试剂的制备将使我们能够使用Western blotting来筛选响应IGF-1处理的ADP核糖化蛋白。 意义:这项研究将阐明我们已经确定的新的效应器如何有助于从典型的酪氨酸激酶受体的信号转导。此外,我们还将提供酪氨酸激酶受体激活G蛋白的结构机制。目前已知的G(I)-α效应蛋白只有3种,它们在IGF-1信号转导中的作用尚不清楚。弄清ErbB2激活的机制将有助于更好地理解它是如何将G(I)-α与miRNA表达和细胞迁移结合在一起的,从而使我们能够建立一个新的范式来研究G蛋白如何参与RTK信号转导。最后,如果能产生抗体,我们就有了一种工具,可以用来第一次发现ADP-核糖化如何介导IGF-1信号。
英文摘要
Background: Signalling events initiated by insulin-like growth factor-1 (IGF-1) have been typically described as being solely dependent upon receptor tyrosine kinase activation. However, a distinct, G protein-dependent pathway may also exist. While various data have subsequently supported this initial observation, a mechanism explaining how G proteins mediate signals deriving from tyrosine kinase receptors has not yet been identified. Relevant Findings: During the previous funding period, we established that activation of G(i) by IGF-1 in smooth muscle cells involves direct binding of G(i) to the IGF-1 receptor and showed that G-beta/gamma subunit activation mediates the pathway leading to ERK1/2. We also identified several novel effectors of G(i)-alpha (ErbB2, EGFR, eIF-4E, histone H2b). A unique feature of the latter finding is the identification of a role for G(i) in coupling two receptor tyrosine kinases, IGF-1R and ErbB2, via a transactivation mechanism. Hypothesis: Binding of G(i) to a specific site on the IGF-1 receptor is required for activation of ErbB2, which subsequently promotes cell migration by modulating expression of microRNAs that control cytoskeletal dynamics. Objectives: 1. To determine the structural factors that mediate the binding of G(i) to the IGF-1 receptor. 2. To explore the role of ErbB2 in IGF-1 signalling, miRNA expression and cell migration. 3. To produce an antibody for monitoring mono-ADP-ribosylation by immunoblotting. Experimental Approach: 1. GST-tagged G(i)-alpha will serve as bait for recombinant active IGF-1 receptor in a pull-down assay. The association between bait and receptor will be quantified by Western blotting. The binding site of G(i)-alpha with IGF-1 receptor will be mapped through systematic mutation of the recombinant IGF-1 receptor, initially by deletion of 10 amino acid sections and followed by individual point mutations once the region of interaction has been defined. A representative mutation that is incapable of binding G(i)-alpha will then be cloned in a lentivirus vector and expressed in cells challenged with IGF-1 to verify loss of function. 2. The role of ligand-dependent and ligand-independent ErbB2 activation by G(i)-alpha will be explored via pretreatment with TAPI-2, an ADAM17-specific inhibitor, and the cytohesin inhibitor SecinH3, respectively, and subsequent stimulation with IGF-1. ErbB2 phosphorylation will be monitored by Western blotting. The role of ErbB2 in cell migration and miRNA expression will be assessed with a selective inhibitor, CP-724714. The contribution of miRNA to ErbB2-dependent migration will be identified by selective miRNA knockdown. 3. We have designed an antigen for producing an antibody to ADP-ribosylated arginine. Preparation of this reagent will enable us to use Western blotting to screen for ADP-ribosylated proteins in response to IGF-1 treatment. Significance: This study will clarify how the new effectors we have identified contribute to the transduction of signals from canonical tyrosine kinase receptors. As well, we will provide a structural mechanism for the activation of a G protein by a tyrosine kinase receptor. At this point in time, only 3 effector proteins of G(i)-alpha are known, and their role in IGF-1 signal transduction is unknown. Identifying the mechanism for ErbB2 activation will provide a better understanding of how it couples G(i)-alpha to miRNA expression and cell migration, thus enabling us to establish a new paradigm for how this G protein contributes to RTK signal transduction. Finally, if an antibody can be produced, we would have a tool that could be used to discover, for the first time, how ADP-ribosylation mediates IGF-1 signalling.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Hormonal mechanisms of gene regulation
  • 批准号:
    RGPIN-2019-06096
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.62万
  • 财政年份:
    2022
  • 负责人:
    Zahradka, Peter
  • 依托单位:
Hormonal mechanisms of gene regulation
  • 批准号:
    RGPIN-2019-06096
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.62万
  • 财政年份:
    2021
  • 负责人:
    Zahradka, Peter
  • 依托单位:
Hormonal mechanisms of gene regulation
  • 批准号:
    RGPIN-2019-06096
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.62万
  • 财政年份:
    2020
  • 负责人:
    Zahradka, Peter
  • 依托单位:
Hormonal mechanisms of gene regulation
  • 批准号:
    RGPIN-2019-06096
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.62万
  • 财政年份:
    2019
  • 负责人:
    Zahradka, Peter
  • 依托单位:
国内基金
海外基金
Exploring the Intrinsic Mechanisms of CEO Turnover and Market
  • 批准号:
    --
  • 项目类别:
    外国学者研究基金
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    HAOFEI Z
  • 依托单位:
Exploring the Intrinsic Mechanisms of CEO Turnover and Market Reaction: An Explanation Based on Information Asymmetry
  • 批准号:
    W2433169
  • 项目类别:
    外国学者研究基金项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    HAOFEI ZHANG
  • 依托单位:
Erk1/2/CREB/BDNF通路在CSF1R相关性白质脑病致病机制中的作用研究
  • 批准号:
    82371255
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    曹立
  • 依托单位:
Foxc2介导Syap1/Akt信号通路调控破骨/成骨细胞分化促进颞下颌关节骨关节炎的机制研究
  • 批准号:
    82370979
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    张善勇
  • 依托单位: